ETRA — Electra Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual cashflow statement for Electra Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -24.8 | -62 |
| Depreciation | ||
| Non-Cash Items | 1.59 | 3.17 |
| Other Non-Cash Items | ||
| Changes in Working Capital | -2.8 | -1.74 |
| Change in Accounts Receivable | ||
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Cash from Operating Activities | -26 | -60.5 |
| Capital Expenditures | 0 | -0.733 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | 29.7 | -52.2 |
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Cash from Investing Activities | 29.7 | -53 |
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 0 | 132 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 3.7 | 18.2 |